United Therapeutics (UTHR) Tops Q3 EPS by 194c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $497.27 -0.24%
Revenue Growth %: -1.2%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -1.2%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.91, $1.94 better than the analyst estimate of $1.97. Revenue for the quarter came in at $330 million versus the consensus estimate of $335.1 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Cargojet Inc. (CJT:CN) (CGGJF) PT Raised to $128 at TD Cowen, maintains bullish call
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
